Brief: Heidelberg Pharma H1 Net Loss Widens To EUR 13.1 Million

Heidelberg Pharma AG

08/07/2021 06:14

July 8 (Reuters) - HEIDELBERG PHARMA AG  HPHA.DE :
    * REPORTS ON FIRST HALF-YEAR 2021
    * OPERATING RESULT IN LINE WITH PLANNING
    * H1 SALES REVENUE AND INCOME TOTALING EUR 1.1 MILLION, THUS
FALLING SHORT OF PRIOR-YEAR FIGURE OF EUR 3.8 MILLION
    * NET LOSS POSTED BY HEIDELBERG PHARMA GROUP FOR FIRST SIX
MONTHS
OF 2021 CAME TO EUR 13.1 MILLION (PREVIOUS YEAR: EUR 9.4
MILLION)
    * OUTLOOK 2021: CONFIRMS ITS FULL-YEAR FINANCIAL GUIDANCE

Source text for Eikon:  ID:nEQ6GMgk2a 
Further company coverage:  HPHA.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))